Brief: Verve Therapeutics Q4 EPS USD -0.69
Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 5.143 million. * Q4 net income USD -48.353 million * Q4 EPS USD -0.69
Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 5.143 million. * Q4 net income USD -48.353 million * Q4 EPS USD -0.69